The cancer pathology gene large model DeepGEM is implemented

On October 23rd, reporters learned from Guangzhou Kingmed Diagnostics Group Co., Ltd. that the cancer pathology gene large model DeepGEM has recently been deployed at the company. Relying on this large model, the company will collaborate with Tencent and the First Affiliated Hospital of Guangzhou Medical University to jointly develop a multimodal large model for pathological genes, allowing accurate, timely, and accessible gene mutation prediction technologies to benefit more cancer patients